HYPR Stock Catalyst: Hyperfine, Inc. Secures FDA Clearance for Next-Generation AI-Powered Portable MRI Scanner

Hyperfine, Inc. (Nasdaq: HYPR) announced it has received clearance from the U.S. Food and Drug Administration (FDA) for its next-generation AI-powered portable MRI scanner. The clearance enables the company to market and sell the device in the United States.

The new MRI scanner leverages artificial intelligence to provide high-quality imaging in a portable format, aiming to enhance accessibility and efficiency in medical diagnostics. This advancement represents a significant step forward in Hyperfine's mission to make MRI technology more accessible to healthcare providers and patients.

As of the latest available data, Hyperfine, Inc. has a free float of 77,866,000 shares and 82,113,000 shares outstanding.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.